![](/img/cover-not-exists.png)
Secukinumab, a novel anti-IL-17A antibody, exhibits low immunogenicity in clinical trials and human in vitro assays
Kolbinger, Frank, Blauvelt, Andrew, Armstrong, April, Fox, Todd, Huang, Jiaqing, Liang, Eric, Karle, Annette, Spindeldreher, Sebastian, Bruin, Gerard, Reich, KristianVolume:
84
Language:
english
Journal:
Journal of Dermatological Science
DOI:
10.1016/j.jdermsci.2016.08.367
Date:
October, 2016
File:
PDF, 60 KB
english, 2016